Sanofi Biotechnology was granted a patent for rheumatoid arthritis treatment compositions.

{
  "signal_id": "5f087801-5bba-5874-b8b8-fea64b526d01",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-09-30T17:01:46+00:00",
  "company": {
    "name": "Sanofi",
    "domain": "sanofi.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C22C 19/058"
      },
      {
        "code": "A61K 31/42"
      },
      {
        "code": "A61K 31/4706"
      },
      {
        "code": "A61K 31/519"
      },
      {
        "code": "A61K 31/635"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Healthcare Technology"
    ],
    "detail": "In September 2026 Sanofi Biotechnology patented combination therapy for treating rheumatoid arthritis and improving symptoms in clinical care.",
    "summary": "Sanofi Biotechnology was granted a patent for rheumatoid arthritis treatment compositions.",
    "event_at": "2026-09-29",
    "inventors": [
      {
        "name": "Xiaohong Huang",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Martine Jasson",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/martine-jasson-b003662a"
      },
      {
        "name": "Vanessa Marks",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Allen Radin",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/allen-radin-77660a9"
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-09-29",
    "source_url": "https://patents.google.com/patent/US12747487",
    "cpc_primary": {
      "code": "C22C 19/058"
    },
    "patent_title": "Compositions for the treatment of rheumatoid arthritis and methods of using same",
    "patent_number": "US12747487",
    "uspto_assignee": "SANOFI BIOTECHNOLOGY",
    "patent_abstract": "The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.",
    "precision_class": "structural",
    "invention_explanation": "A treatment that pairs an antibody targeting the human interleukin-6 receptor with a disease-modifying antirheumatic drug to reduce rheumatoid arthritis symptoms.",
    "technologies_mentioned": [
      "therapeutic antibodies",
      "interleukin-6 receptor targeting",
      "DMARD combination therapy"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/5f087801-5bba-5874-b8b8-fea64b526d01 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"sanofi.com","limit":20}'